Company Financials
EntreMed's ENMD-2076 Active In Solid And Hematological Cancers
Nov 17, 2009 ... EntreMed, Inc. ( ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer announced the ...
http://www.medicalnewstoday.com/articles/171085.php
Nov 17, 2009 ... EntreMed, Inc. ( ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer announced the ...
http://www.medicalnewstoday.com/articles/171085.php
EntreMed, Inc. » Archive » EntreMed's ENMD-2076 Active in Solid ...
EntreMed has received orphan drug designation for the use of ENMD-2076 in ovarian cancer patients and the Phase 2 study is expected to commence in the ...
http://www.entremed.com/news/entremed%E2%80%99s-enmd-2076-active-in-solid-and-hemato...
EntreMed has received orphan drug designation for the use of ENMD-2076 in ovarian cancer patients and the Phase 2 study is expected to commence in the ...
http://www.entremed.com/news/entremed%E2%80%99s-enmd-2076-active-in-solid-and-hemato...
StreetInsider.com - EntreMed (ENMD) Presents ENMD-2076 Data at ASCO
Jun 1, 2009 ... EntreMed's ENMD-2076 Active in Solid and Hematological Cancers ... EntreMed, Inc . (Nasdaq: ENMD) announced the presentation of clinical data ...
http://www.streetinsider.com/FDA/EntreMed+(ENMD)+Presents+ENMD-2076+Data+at+ASCO/469...
Jun 1, 2009 ... EntreMed's ENMD-2076 Active in Solid and Hematological Cancers ... EntreMed, Inc . (Nasdaq: ENMD) announced the presentation of clinical data ...
http://www.streetinsider.com/FDA/EntreMed+(ENMD)+Presents+ENMD-2076+Data+at+ASCO/469...
Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR ...
Nov 3, 2009 ... ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - News), a clinical-stage pharmaceutical company developing ...
http://biz.yahoo.com/prnews/091103/ph03723.html?.v=1
Nov 3, 2009 ... ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - News), a clinical-stage pharmaceutical company developing ...
http://biz.yahoo.com/prnews/091103/ph03723.html?.v=1
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
E
EntreMed
EntreMed's mission as the Angiogenesis company is to discover, develop and commercialize antiangiogenic therapeutics which have the potential to treat diseases associated with angiogenesis including cancer and blindness.
www.entremed.com
EntreMed's mission as the Angiogenesis company is to discover, develop and commercialize antiangiogenic therapeutics which have the potential to treat diseases associated with angiogenesis including cancer and blindness.
www.entremed.com
